In addition to painkillers such as ketorolac, other important drugs such as diclofenac, ketoprofen and drotaverine will be produced in the new workshop number 8. The aim of this step is to ensure import substitution and increase the country’s self-sufficiency in medicine.
The company’s plans include increasing product production to more than 210 million packages this year, 24% more than in 2023. 59 new products have already been added to the product range, and 40 more are planned to be introduced by the end of the year, including tolperisone, bisacodyl and clarithromycin.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
